We found a higher infiltration of antitumor immune cells (CD8+ T cells, TAMs, and NK cells) in gliomas with high PTPN2 expression, which is not in agreement with a previous study that reports a significant increase in the number of CD8α+ cells in PTPN2-deficient tumors [17]. The gene discussed is CD8A; the disease is central nervous system cancer.